Literature DB >> 24853835

Puerperal retroperitoneal abscess caused by Clostridium difficile: case report and review of the literature.

Tuangsit Wataganara1, Anuwat Sutantawibul, Sanitra Anuwutnavin, Amornrut Leelaporn, Young Rongrungruang.   

Abstract

BACKGROUND: Retroperitoneal infection can be lethal. Optimal management is still elusive to describe because of the small number of case reports. We presented here a case of retroperitoneal abscess caused by Clostridium difficile arising in the puerperal period.
METHODS: Case report and review of recent English-language literature.
RESULTS: The patient presented with surgical incision dehiscence. A gas-forming fluid collection was discovered in the pelvic retroperitoneal fascia by computed tomography, but the patient did not show marked symptoms of sepsis. Emergency laparotomy drainage and debridement were performed. Clostridium difficile was isolated, and she was treated with a three-week course of vancomycin. The patient recovered without major morbidity. Recent case reports describe variation in the course of the disease and management options for puerperal retroperitoneal infection.
CONCLUSION: Puerperal retroperitoneal abscess caused by C. difficile can present with minimal symptoms. Prompt recognition, early surgical intervention, and optimal use of antibiotics can reduce morbidity and prevent death.

Entities:  

Mesh:

Year:  2014        PMID: 24853835     DOI: 10.1089/sur.2012.104

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  2 in total

1.  Retroperitoneal abscess with pylephlebitis caused by lumbar acupuncture: a case report.

Authors:  Hayemin Lee; Kiyoung Sung; Jinbeom Cho
Journal:  BMC Surg       Date:  2019-10-16       Impact factor: 2.102

2.  Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome.

Authors:  Fei Li; Ying Chen; Aiqin Niu; Yajing He; Ying Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-06       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.